2005
DOI: 10.1080/09513590400021086
|View full text |Cite
|
Sign up to set email alerts
|

Effect of menstrual cycle and hormonal treatment on ki-67 and bcl-2 expression and adenomyosis

Abstract: During the luteal phase, both ki-67 and bcl-2 expression is reduced in adenomyotic lesions in a similar way to that occurring in patients using Mirena. Oral contraceptives, on the other hand, do not affect bcl-2 expression in adenomyosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2006
2006
2013
2013

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 12 publications
references
References 14 publications
0
0
0
Order By: Relevance